Mercy BioAnalytics has filed a notice of an exempt offering of securities to raise $41,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Mercy BioAnalytics is raising $41,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Dawn Mattoon played a key role…